Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,560 | -11,606 | -7,867 | -5,337 | -2,648 |
| Depreciation Amortization | 24 | 126 | 100 | 71 | 44 |
| Accounts receivable | -4 | 27 | 19 | 32 | 2 |
| Other Working Capital | -498 | 859 | 82 | -4 | 225 |
| Other Operating Activity | 1,298 | 159 | 100 | 29 | 4 |
| Operating Cash Flow | $-3,740 | $-10,435 | $-7,566 | $-5,209 | $-2,373 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,581 | 3,506 | 1,510 | -2,936 | -3,567 |
| PPE Investments | -36 | -182 | -166 | -136 | -87 |
| Investing Cash Flow | $2,545 | $3,325 | $1,344 | $-3,072 | $-3,654 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,719 | 16 | 4 | 4 | 0 |
| Financing Cash Flow | $5,719 | $16 | $4 | $4 | $0 |
| Beginning Cash Position | 2,063 | 9,157 | 9,157 | 9,157 | 9,157 |
| End Cash Position | 6,587 | 2,063 | 2,939 | 880 | 3,131 |
| Net Cash Flow | $4,524 | $-7,095 | $-6,218 | $-8,278 | $-6,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,740 | -10,435 | -7,566 | -5,209 | -2,373 |
| Capital Expenditure | -36 | -182 | -166 | -136 | -87 |
| Free Cash Flow | -3,776 | -10,617 | -7,732 | -5,346 | -2,460 |